Oral diabetes medication study
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests an investigational pill for people with type 2 diabetes whose blood sugar is not well controlled despite lifestyle changes or metformin. The pill may help improve blood sugar control and is taken by mouth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 75 years old
- Have had type 2 diabetes for at least 3 months
- Currently on a stable dose of metformin (or lifestyle changes) for at least 3 months, but blood sugar is still too high
- Your A1c (average blood sugar over 3 months) is between 7.5% and 11.0%
- Your weight is within a certain range (BMI 20 to 40)
- No major diabetes complications like severe kidney, eye, or nerve problems
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if starting two newer diabetes drugs (empagliflozin and semaglutide) soon after diagnosis, along with metformin, helps control blood sugar better than metformin alone. It's for people diagnosed with type 2 diabetes in the last two years who are already taking a high dose of metformin.
This study tests a new medication called PG-102 against a placebo and an existing medication (semaglutide) to see how well it controls blood sugar in people with type 2 diabetes. It may offer a new treatment option that could help lower your blood sugar levels.
This trial tests an experimental pill called DA-302168S to see if it helps lower blood sugar in people with type 2 diabetes. It is for patients who are already managing their diabetes with metformin or lifestyle changes, and it focuses on safety and effectiveness over about 6 months.
This study tests a new once-weekly injectable medication (HDM1005) for people with type 2 diabetes whose blood sugar is not well controlled by diet and exercise or metformin alone. It aims to help lower blood sugar and may also support weight loss.
This trial tests an experimental daily tablet for adults with type 2 diabetes who are not currently on any diabetes medication. It aims to see if the tablet can safely lower blood sugar levels over time.
This study tests a new medicine, NNC0662-0419, in people with type 2 diabetes. You must be willing to lose a lot of weight (more than a quarter of your current weight) as part of the study to see if the medicine helps lower blood sugar.
Hear when a new Type 2 Diabetes Mellitus (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.